xCARE
xCARE is a Tokyo-based expert matching platform that connects Japanese pharmaceutical, medical device, and bio-venture companies with 500+ vetted senior professionals for spot contracts, project support, and hybrid recruitment across the drug and device development lifecycle.
- Company typePrivate
- Founded2022
- HeadquartersTokyo, Japan
- Headcount1–10
- GTM typeB2B
- OfferingServices
What xCARE does
xCARE, Inc. is a Tokyo-based expert matching platform operating in the pharmaceutical and medical device development segment of the Japanese life-sciences services market. The company connects bio-ventures, pharmaceutical companies, medical device firms, and academic institutions with a curated pool of 500+ registered senior professionals, supported by a broader 70,000-contact professional network used for sourcing candidates. According to company materials, 80% of registered experts have 20+ years of industry experience, including former PMDA auditors, CRO executives, and pharmaceutical company senior leaders such as the former EVP of Astellas Pharma.
The platform delivers three core services: spot contracting of individual experts (starting from 5 hours per month / 1-month minimums) at disclosed rates of approximately ¥8,000–¥15,000 per hour depending on specialty (CMC strategy, regulatory affairs, IP research); hands-on project support where xCARE coordinators and experts embed as project team members for medium-to-long-term engagements; and hybrid recruitment combining spot contracts with eventual full-time placements to optimize personnel costs across development phases. Customers cited in case studies include Helios (HLCM051 approval support), Heart Lab (QMS construction and PMDA approval for SaMD within six months), Toregem Bio Pharma (CMC strategy for tooth regeneration antibody), Dioseve (iPS cell FDA/PMDA audit support), AMI (QMS refresh and FDA strategy), and Sapporo Medical University (commercialization support).
Commercially, xCARE operates a sales-led B2B go-to-market with no resellers, capturing demand through website inquiry forms, content marketing, recurring seminar programs, and free consultation diagnostics, then scoping engagements through coordinator-led matching. Revenue is generated on a professional-services basis per engagement. To date the company has raised approximately ¥730 million in aggregate (¥130M seed in 2024 plus ¥600M Series A in July 2026), with investors including ANRI, CyberAgent Capital, Chugin Capital Partners, Primal Capital, Kyoto University Innovation Capital, and mint, the latter as Series A lead. Series A proceeds are designated for AI integration into the matching workflow, expansion of the expert network, and organizational buildout.
xCARE firmographics
Firmographics- Name
- xCARE
- Legal name
- xcare,Inc.
- Website
- https://xcareplatform.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- xCARE is a Tokyo-based expert matching platform that connects Japanese pharmaceutical, medical device, and bio-venture companies with 500+ vetted senior professionals for spot contracts, project support, and hybrid recruitment across the drug and device development lifecycle.
- Ownership category
- akta.pro rank
xCARE industry classification
Industry- Product category
- Pharmaceutical & Medical Device Consulting
- NAICS
- Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA)
- akta.pro secondary industry
- Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)
Keywords
Where xCARE is headquartered
LocationHeadquarters
- HQ city
- Tokyo
- HQ country
- Japan
- HQ region
- Asia
Offices1 record
Markets served
xCARE business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Expert Spot Contract Services: Contracting expert professionals on a monthly/hourly basis (starting from 1 month / 5 hours per month) for pharmaceutical and medical device development advisory and execution support.
- Project Support Services: Hands-on project management and support services where xCARE coordinators and registered experts collaborate as project team members for medium to long-term engagement.
- Hybrid Recruitment Services: Combination of spot contracting and full-time placement services to optimize personnel costs while meeting development phase requirements, leveraging the 70,000+ network for candidate sourcing.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Usage-based | Monthly | Spot contract starting from 1 month / 5 hours per month engagement |
| Unit Pricing | Pay-as-you-go | CMC Strategy Advisory projects at ¥8,000/hour |
| Unit Pricing | Pay-as-you-go | Program Medical Device Regulatory Strategy at ¥10,000/hour |
| Unit Pricing | Pay-as-you-go | Pharmaceutical Intellectual Property Research at ¥15,000/hour |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
xCARE product offering
Product offeringCore offering
xCARE operates an expert matching platform specialized for pharmaceutical and medical device development. The company connects bio ventures, pharmaceutical firms, medical device companies, and academic institutions with 500+ vetted registered experts (accessing a network of 70,000+ professionals) for spot contracts, hands-on project support, and hybrid recruitment. Services cover non-clinical and clinical trials, CMC development, regulatory affairs, QMS design, and global market entry.
Product overview
xCARE is a specialized expert platform for pharmaceutical and medical device development, offering three core services: Expert Spot Contract, Project Support, and Hybrid Recruitment. The platform connects companies with over 500 registered experts (with access to a network of 70,000+) across clinical trials, CMC, regulatory affairs, QMS, and global market entry. The company also provides educational seminars as a supplementary service. xCARE operates as a matching platform rather than a traditional software product.
Differentiator
Problem solved
Functional benefit
Products and services
- xCARE Expert Spot Contract Service On-demand expert contracting service connecting companies with 500+ specialized professionals (including former pharma heads and clinical development directors with 20+ years experience) for pharmaceutical and medical device development advisory and execution support. Clients can engage experts from 1 month / 5 hours per month for tasks including document preparation, CRO management, and advisory work.
- xCARE Project Support Service Hands-on project support service where xCARE's experienced consultants and registered experts collaborate as project team members, providing medium to long-term support including planning, team management, trial scheduling, CRO selection, and regulatory strategy execution for pharmaceutical and medical device development projects.
- Hybrid Recruitment Service Hybrid hiring service combining spot contracts with full-time recruitment, allowing optimization of personnel costs based on development phase. xCARE's network of 70,000+ professionals supports finding optimal organizational structures that blend contract expertise with permanent hires.
- Seminars Practical educational seminars for pharmaceutical and medical device development covering topics including overseas regulatory affairs PM practice, R&D organizational cost optimization, market access fundamentals, non-clinical CRO selection, SaMD strategy, and CMC development. Both live sessions and archived recordings are available.
Quantifiable outcome
- Achieved regulatory approval within 6 months for Heart Lab's medical device
- +4 more outcomes
Companies that use xCARE
Customer profileNamed customers11 records
Segments4 records
Ideal customer profiles4 records
xCARE technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
xCARE partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights6 records
xCARE competitors and assessment
Company assessmentBroad incumbents
- CMIC Group: Japan's largest CRO offering end-to-end pharma development services including clinical operations, regulatory, CMC, and post-marketing. Competes with xCARE for the same Japanese pharma/biotech customers across overlapping service categories, but operates at much larger scale and provides bundled solutions rather than expert matching.
- Experis Life Sciences: Global staffing and FSP provider dedicated to life sciences, offering contract, permanent, and functional service provider arrangements across pharma and medical device clients. Comparable in life sciences staffing/FSP focus; xCARE differs via curated platform model and Japan-centric operations.
- Hays Life Sciences: Global recruitment and staffing firm with dedicated life sciences practice covering pharma, biotech, medical device, and CRO sectors. Comparable in life sciences talent placement; differs via traditional recruitment agency model and global rather than Japan-specific focus.
Direct peers
- A2 Healthcare Corporation: Japanese CRO providing clinical trial management, monitoring, and regulatory affairs services to pharma and biotech clients in Japan. Directly comparable in customer segment (Japanese pharma/biotech) and service scope (clinical operations, regulatory), differing mainly in delivery model (full-service CRO vs. expert matching platform).
- Gerson Lehrman Group (GLG): Global expert network platform connecting professionals with consulting, investment, and corporate clients. Closest comparable on platform business model (vetted expert network, on-demand expert engagements), though GLG covers broader industries and serves consulting clients; xCARE specializes in Japanese pharma/medical device.
- AlphaSights: Global expert network serving investment, consulting, and corporate clients with on-demand expert consultations. Shares the core business model of curated expert matching with xCARE, but operates globally across industries; xCARE is narrower in domain focus (life sciences) and geography (Japan).
- Guidepoint: Expert network platform providing on-demand expert consultations across industries. Directly comparable business model (vetted expert network, consultation-based delivery) but broader in industry scope; xCARE is more specialized in life sciences and embedded with operational/hands-on project support beyond advisory calls.
Emerging players
- InCROM (formerly InC Research): Japanese CRO providing clinical research and consulting services to biotech and pharma companies in Japan. Comparable in target market (Japanese bio ventures and pharma) and service categories (clinical, regulatory), though operates under traditional CRO delivery model versus xCARE's expert matching model.
- Toptal: Global freelance talent platform connecting businesses with vetted experts across many disciplines. Comparable platform business model (curated expert network, on-demand engagement), but operates broadly across industries and geographies; xCARE specializes in Japanese pharma/medical device development.
Others
- Medipal Holdings: Japanese pharma distribution and services conglomerate with adjacent business in pharmaceutical contract services and medical device distribution. Thematically related as Japanese healthcare/pharma services ecosystem participant; serves overlapping pharma customers though core distribution business differs from xCARE's expert matching model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
xCARE social profiles
Digital presencexCARE financial estimates
Financial estimateRevenue estimate
Valuation estimate
xCARE leadership team
Management profileNumber of profiles
Profiles6 records
xCARE funding detail
Funding detailFunding overview
Funding rounds4 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
xCARE M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about xCARE
What does xCARE do?
xCARE operates an expert matching platform specialized for pharmaceutical and medical device development. The company connects bio ventures, pharmaceutical firms, medical device companies, and academic institutions with 500+ vetted registered experts (accessing a network of 70,000+ professionals) for spot contracts, hands-on project support, and hybrid recruitment. Services cover non-clinical and clinical trials, CMC development, regulatory affairs, QMS design, and global market entry.
Is xCARE a public or private company?
xCARE is a private company. It is classified as venture growth investor backed and is currently operating.
When was xCARE founded?
xCARE was founded in 2022. It employs 1 to 10 people.
Where is xCARE based?
xCARE is headquartered in Tokyo, Japan, in the Asia region.
How does xCARE make money?
Three revenue lines are on record. Expert Spot Contract Services are the primary driver. The others are project Support Services and hybrid Recruitment Services.
Who are xCARE's main competitors?
Broad incumbents on record are CMIC Group, Experis Life Sciences and Hays Life Sciences. Direct peers are A2 Healthcare Corporation, Gerson Lehrman Group (GLG), AlphaSights and Guidepoint. Emerging players are InCROM (formerly InC Research) and Toptal. Medipal Holdings is listed as an others.
Does xCARE have an API?
No public API is recorded for xCARE.
What industry is xCARE in?
xCARE's product category is Pharmaceutical & Medical Device Consulting. Its primary akta.pro industry code is HLAGAOAA, Clinical Operations & Monitoring FSP (CRA/CTM/Start-up), with a secondary code of HLAGAKAI, Clinical Quality Assurance (GCP QA, TMF/QMS oversight). Its NAICS code is 54169 and its SIC code is 8000.